/**
 * Topics Content - Konu Ã–zetleri Veri DosyasÄ±
 * KapsamlÄ± konu anlatÄ±mlarÄ±
 */

const topicsData = [
    {
        id: 1,
        category: "bakteriyoloji",
        title: "Bacillus anthracis",
        subtitle: "Åarbon (Antraks) Etkeni",
        summary: "Gram pozitif, spor oluÅŸturan, aerob, hareketsiz, kapsÃ¼llÃ¼ basil. Biyolojik silah potansiyeli olan, Ã¼Ã§ klinik formda (deri, solunum, gastrointestinal) hastalÄ±k yapan Ã¶nemli bir patojendir.",
        tags: ["Gram Pozitif", "Spor Yapan", "Biyolojik Silah", "Toksin", "Zoonoz"],
        sections: [
            {
                title: "Genel Ã–zellikler",
                icon: "fas fa-microscope",
                content: `
                    <p><strong>Bacillus anthracis</strong>, Bacillus cinsinin en Ã¶nemli insan patojenidir. Gram pozitif, aerob, hareketsiz, bÃ¼yÃ¼k (1-1.5 Ã— 3-10 Î¼m), uÃ§larÄ± kÃ¶ÅŸeli basil morfolojisindedir.</p>
                    
                    <div class="highlight-box">
                        <p class="highlight-box__title">TanÄ±mlayÄ±cÄ± Ã–zellikler</p>
                        <p class="highlight-box__content">
                            <strong>"Bambu KamÄ±ÅŸÄ±" veya "Vagon Dizisi"</strong> gÃ¶rÃ¼nÃ¼mÃ¼ - Zincirlerde uÃ§ uca dizilmiÅŸ basiller karakteristiktir. Boyama ile metakromatik granÃ¼ller gÃ¶rÃ¼lebilir.
                        </p>
                    </div>

                    <ul class="feature-list">
                        <li class="feature-item"><b>Spor:</b> Merkezi veya submerkezi, hÃ¼creyi ÅŸiÅŸirmez (subterminal), eliptik</li>
                        <li class="feature-item"><b>KapsÃ¼l:</b> Poly-D-glutamik asit (protein yapÄ±da, antifagositik) - pXO2 plazmidi kodlar</li>
                        <li class="feature-item"><b>Hareket:</b> HAREKETSÄ°Z (diÄŸer Bacillus tÃ¼rlerinden ayÄ±rÄ±cÄ±!)</li>
                        <li class="feature-item"><b>Hemoliz:</b> Non-hemolitik veya zayÄ±f hemolitik (B. cereus gÃ¼Ã§lÃ¼ Î²-hemolitik)</li>
                        <li class="feature-item"><b>Katalaz:</b> Pozitif</li>
                    </ul>

                    <div class="alert-box alert-box--warning">
                        <span class="alert-box__icon">âš ï¸</span>
                        <p class="alert-box__text"><strong>Dikkat:</strong> B. anthracis HAREKETSÄ°Z, NON-HEMOLÄ°TÄ°K'tir. B. cereus ise hareketli ve Î²-hemolitik. Bu Ã¶zellikler ayÄ±rÄ±cÄ± tanÄ±da kritiktir!</p>
                    </div>
                `
            },
            {
                title: "VirÃ¼lans FaktÃ¶rleri",
                icon: "fas fa-biohazard",
                content: `
                    <p>B. anthracis'in virÃ¼lansÄ± <strong>iki bÃ¼yÃ¼k plazmide</strong> baÄŸlÄ±dÄ±r. Her iki plazmid de tam virÃ¼lans iÃ§in gereklidir:</p>

                    <table class="article-table">
                        <tr>
                            <th>Plazmid</th>
                            <th>KodladÄ±ÄŸÄ±</th>
                            <th>Fonksiyon</th>
                        </tr>
                        <tr>
                            <td><b>pXO1</b> (182 kb)</td>
                            <td>Toksin genleri (pagA, lef, cya)</td>
                            <td>Antraks toksini Ã¼retimi</td>
                        </tr>
                        <tr>
                            <td><b>pXO2</b> (96 kb)</td>
                            <td>KapsÃ¼l genleri (capBCAD)</td>
                            <td>Antifagositik kapsÃ¼l</td>
                        </tr>
                    </table>

                    <div class="sub-section">
                        <h4 class="sub-section__title">Antraks Toksini (A-B Toksin Modeli)</h4>
                        <p>ÃœÃ§ ayrÄ± protein birlikte Ã§alÄ±ÅŸarak toksin etkisi oluÅŸturur:</p>
                        <ul class="feature-list">
                            <li class="feature-item"><b>Protective Antigen (PA):</b> B komponenti - HÃ¼cre yÃ¼zeyine baÄŸlanÄ±r, diÄŸer iki komponentin giriÅŸini saÄŸlar</li>
                            <li class="feature-item"><b>Edema Factor (EF):</b> Adenilat siklaz aktivitesi - cAMPâ†‘ â†’ Masif Ã¶dem</li>
                            <li class="feature-item"><b>Lethal Factor (LF):</b> Ã‡inko metaloproteaz - MAPK yolaÄŸÄ±nÄ± keser â†’ Makrofaj Ã¶lÃ¼mÃ¼, sitokin fÄ±rtÄ±nasÄ±</li>
                        </ul>
                    </div>

                    <div class="highlight-box">
                        <p class="highlight-box__title">Toksin KombinasyonlarÄ±</p>
                        <p class="highlight-box__content">
                            <strong>PA + EF = Ã–dem Toksini</strong> (lokal Ã¶dem)<br>
                            <strong>PA + LF = Letal Toksin</strong> (ÅŸok, Ã¶lÃ¼m)
                        </p>
                    </div>

                    <div class="alert-box alert-box--info">
                        <span class="alert-box__icon">â„¹ï¸</span>
                        <p class="alert-box__text"><strong>SÄ±nav Notu:</strong> Antraks toksin genleri <strong>plazmid (pXO1)</strong> kaynaklÄ±dÄ±r, FAJ KAYNAKLI DEÄÄ°LDÄ°R! Difteri, kolera, shiga toksinleri faj kaynaklÄ±yken, antraks toksini plazmid kodlar.</p>
                    </div>
                `
            },
            {
                title: "Klinik Formlar",
                icon: "fas fa-user-injured",
                content: `
                    <p>Antraks Ã¼Ã§ ana klinik formda karÅŸÄ±mÄ±za Ã§Ä±kar. BulaÅŸ yoluna gÃ¶re form deÄŸiÅŸir:</p>

                    <div class="sub-section">
                        <h4 class="sub-section__title">1. Deri Antraksi (%95)</h4>
                        <ul class="feature-list">
                            <li class="feature-item">En sÄ±k form, en iyi prognoz (%1 mortalite tedavisiz, %20 tedavisiz)</li>
                            <li class="feature-item"><b>BulaÅŸ:</b> SporlarÄ±n deriye temasÄ± (kesik, sÄ±yrÄ±k)</li>
                            <li class="feature-item"><b>Lezyon:</b> PapÃ¼l â†’ VezikÃ¼l â†’ <b>ESKÄ°RAR (siyah kabuk)</b> - AÄŸrÄ±sÄ±z!</li>
                            <li class="feature-item"><b>"Malignant pustule"</b> veya <b>"Charbon" (kÃ¶mÃ¼r)</b> adÄ± lezyondan gelir</li>
                            <li class="feature-item">Ã‡evresinde jelatinÃ¶z Ã¶dem (toksin etkisi)</li>
                        </ul>
                    </div>

                    <div class="sub-section">
                        <h4 class="sub-section__title">2. Solunum (Pulmoner/Ä°nhalasyon) Antraksi</h4>
                        <ul class="feature-list">
                            <li class="feature-item">En aÄŸÄ±r form, %90-100 mortalite (geÃ§ tanÄ±)</li>
                            <li class="feature-item"><b>BulaÅŸ:</b> Spor inhalasyonu (yÃ¼n, deri iÅŸÃ§ileri - "Woolsorter's disease")</li>
                            <li class="feature-item"><b>BaÅŸlangÄ±Ã§:</b> Grip benzeri (ateÅŸ, Ã¶ksÃ¼rÃ¼k, miyalji)</li>
                            <li class="feature-item"><b>Ä°lerleme:</b> Hemorajik mediastinit, <b>mediastinal geniÅŸleme (PA akciÄŸer grafisi)</b></li>
                            <li class="feature-item"><b>Son dÃ¶nem:</b> Dispne, siyanoz, ÅŸok, Ã¶lÃ¼m (24-36 saat iÃ§inde)</li>
                        </ul>
                        <div class="alert-box">
                            <span class="alert-box__icon">ğŸš¨</span>
                            <p class="alert-box__text">AkciÄŸer grafisinde <strong>mediastinal geniÅŸleme</strong> gÃ¶rÃ¼lmesi pulmoner antraksÄ± dÃ¼ÅŸÃ¼ndÃ¼rÃ¼r! (Hemorajik lenfadenit)</p>
                        </div>
                    </div>

                    <div class="sub-section">
                        <h4 class="sub-section__title">3. Gastrointestinal Antraks</h4>
                        <ul class="feature-list">
                            <li class="feature-item">Nadir, %25-60 mortalite</li>
                            <li class="feature-item"><b>BulaÅŸ:</b> Kontamine et tÃ¼ketimi (az piÅŸmiÅŸ)</li>
                            <li class="feature-item"><b>Orofaringeal form:</b> BoÄŸazda Ã¼lser, Ã¶dem, lenfadenopati</li>
                            <li class="feature-item"><b>Ä°ntestinal form:</b> KarÄ±n aÄŸrÄ±sÄ±, kanlÄ± ishal, asit, ÅŸok</li>
                        </ul>
                    </div>

                    <div class="sub-section">
                        <h4 class="sub-section__title">4. Enjeksiyon Antraksi (Yeni tanÄ±mlanan)</h4>
                        <ul class="feature-list">
                            <li class="feature-item">IV uyuÅŸturucu kullanÄ±cÄ±larÄ±nda (kontamine eroin)</li>
                            <li class="feature-item">Derin yumuÅŸak doku enfeksiyonu, nekrotizan fasiit benzeri</li>
                            <li class="feature-item">Avrupa'da salgÄ±nlar bildirilmiÅŸ</li>
                        </ul>
                    </div>
                `
            },
            {
                title: "Laboratuvar TanÄ±sÄ±",
                icon: "fas fa-flask",
                content: `
                    <p>TanÄ± klinik ÅŸÃ¼phe ile baÅŸlar. <strong>BiyogÃ¼venlik dÃ¼zey 3 (BSL-3)</strong> laboratuvar ÅŸartlarÄ± Ã¶nerilir ancak rutin iÅŸlemler BSL-2'de yapÄ±labilir.</p>

                    <table class="article-table">
                        <tr>
                            <th>YÃ¶ntem</th>
                            <th>Bulgu</th>
                            <th>Not</th>
                        </tr>
                        <tr>
                            <td>Gram boyama</td>
                            <td>Gram (+) bÃ¼yÃ¼k basil, zincir</td>
                            <td>"Bambu kamÄ±ÅŸÄ±" gÃ¶rÃ¼nÃ¼mÃ¼</td>
                        </tr>
                        <tr>
                            <td>PolisÃ¶m kapsÃ¼l boyama</td>
                            <td>India ink, M'Fadyean</td>
                            <td>Pembe kapsÃ¼l (metilen mavisi)</td>
                        </tr>
                        <tr>
                            <td>KÃ¼ltÃ¼r</td>
                            <td>Koyun kanlÄ± agar, 37Â°C</td>
                            <td>"Medusa baÅŸÄ±" koloni</td>
                        </tr>
                        <tr>
                            <td>Motilite</td>
                            <td>Hareketsiz</td>
                            <td>Kritik ayÄ±rÄ±cÄ± Ã¶zellik</td>
                        </tr>
                        <tr>
                            <td>PCR</td>
                            <td>pXO1, pXO2 genleri</td>
                            <td>HÄ±zlÄ± ve spesifik</td>
                        </tr>
                    </table>

                    <div class="highlight-box">
                        <p class="highlight-box__title">Koloni Morfolojisi</p>
                        <p class="highlight-box__content">
                            <strong>"Medusa baÅŸÄ±"</strong> veya <strong>"Aslan yelesi"</strong> gÃ¶rÃ¼nÃ¼mÃ¼ - Koloniden dÄ±ÅŸa doÄŸru uzanan, kÄ±vrÄ±k zincirler halinde oluÅŸum. Koloni kenarlarÄ± dÃ¼zensiz, mat, yapÄ±ÅŸkan olmayan, gri-beyaz renkte.
                        </p>
                    </div>

                    <ul class="feature-list">
                        <li class="feature-item"><b>Gamma faj lizis testi:</b> B. anthracis'i lizogenik faj tanÄ±r (pozitif = B. anthracis)</li>
                        <li class="feature-item"><b>String of pearls testi:</b> Penisilin varlÄ±ÄŸÄ±nda sferik formlar ("inci dizisi")</li>
                        <li class="feature-item"><b>Bicarbonate agar:</b> COâ‚‚ varlÄ±ÄŸÄ±nda kapsÃ¼l Ã¼retimi artar (mukoid koloni)</li>
                    </ul>
                `
            },
            {
                title: "Tedavi ve Profilaksi",
                icon: "fas fa-pills",
                content: `
                    <p>Tedavi hÄ±zlÄ± baÅŸlamalÄ±dÄ±r. <strong>Antibiyotik + Antitoksin</strong> kombinasyonu aÄŸÄ±r vakalarda kullanÄ±lÄ±r.</p>

                    <div class="sub-section">
                        <h4 class="sub-section__title">Antibiyotik Tedavisi</h4>
                        <ul class="feature-list">
                            <li class="feature-item"><b>Ä°lk seÃ§enek:</b> Siprofloksasin veya Doksisiklin (ampirik)</li>
                            <li class="feature-item"><b>Sistemik hastalÄ±k:</b> IV Siprofloksasin + Meropenem + Linezolid (Ã¼Ã§lÃ¼ kombinasyon)</li>
                            <li class="feature-item"><b>Penisilin:</b> DuyarlÄ±lÄ±k kanÄ±tlanÄ±rsa kullanÄ±labilir (Î²-laktamaz nadir)</li>
                            <li class="feature-item"><b>SÃ¼re:</b> Deri antraksi 7-10 gÃ¼n, sistemik 60 gÃ¼n (spor germinasyonu)</li>
                        </ul>
                    </div>

                    <div class="sub-section">
                        <h4 class="sub-section__title">Antitoksin Tedavisi</h4>
                        <ul class="feature-list">
                            <li class="feature-item"><b>Raxibacumab:</b> Anti-PA monoklonal antikor, FDA onaylÄ±</li>
                            <li class="feature-item"><b>Obiltoxaximab:</b> Anti-PA monoklonal antikor</li>
                            <li class="feature-item"><b>Antraks immÃ¼n globÃ¼lin (AIG):</b> Ä°nsan kaynaklÄ± poliklonal</li>
                        </ul>
                    </div>

                    <div class="sub-section">
                        <h4 class="sub-section__title">AÅŸÄ±</h4>
                        <ul class="feature-list">
                            <li class="feature-item"><b>AVA (Anthrax Vaccine Adsorbed):</b> PA iÃ§eren aselÃ¼ler aÅŸÄ±</li>
                            <li class="feature-item"><b>Endikasyon:</b> YÃ¼ksek riskli meslek gruplarÄ±, askeri personel</li>
                            <li class="feature-item"><b>Åema:</b> 0, 1, 6 ay + yÄ±llÄ±k rapel</li>
                        </ul>
                    </div>

                    <div class="alert-box alert-box--warning">
                        <span class="alert-box__icon">âš ï¸</span>
                        <p class="alert-box__text"><strong>Post-exposure profilaksi:</strong> 60 gÃ¼n antibiyotik + 3 doz aÅŸÄ± (0, 2, 4 hafta). Sporlar akciÄŸerlerde haftalarca canlÄ± kalÄ±p germinasyon yapabilir!</p>
                    </div>
                `
            },
            {
                title: "Epidemiyoloji ve BiyoterÃ¶rizm",
                icon: "fas fa-globe",
                content: `
                    <p>B. anthracis <strong>CDC Kategori A biyoterÃ¶rizm ajanÄ±dÄ±r</strong>. SporlarÄ±n stabilite, Ã¼retim kolaylÄ±ÄŸÄ± ve aerosol yayÄ±lÄ±m potansiyeli kritik tehdit oluÅŸturur.</p>

                    <ul class="feature-list">
                        <li class="feature-item"><b>DoÄŸal bulaÅŸ:</b> Hayvan temasÄ±, hayvansal Ã¼rÃ¼nler (deri, yÃ¼n, kemik unu)</li>
                        <li class="feature-item"><b>Endemik bÃ¶lgeler:</b> TÃ¼rkiye, Orta Asya, Afrika, GÃ¼ney Amerika</li>
                        <li class="feature-item"><b>Risk meslekler:</b> Veteriner, kasap, Ã§iftÃ§i, deri/yÃ¼n iÅŸÃ§isi</li>
                        <li class="feature-item"><b>2001 ABD saldÄ±rÄ±sÄ±:</b> Mektupla yayÄ±lan sporlar, 22 vaka, 5 Ã¶lÃ¼m</li>
                    </ul>

                    <div class="highlight-box">
                        <p class="highlight-box__title">Spor DayanÄ±klÄ±lÄ±ÄŸÄ±</p>
                        <p class="highlight-box__content">
                            Antraks sporlarÄ± toprakta <strong>40+ yÄ±l</strong> canlÄ± kalabilir. Kaynatma, Ã§oÄŸu dezenfektan etkisizdir. <strong>Otoklav (121Â°C, 15 dk)</strong> veya <strong>sporisidal ajanlar</strong> gerekir.
                        </p>
                    </div>

                    <div class="mnemonic-box">
                        <p class="mnemonic-box__label">AyÄ±rÄ±cÄ± Ã–zellikler Ã–zeti</p>
                        <p class="mnemonic-box__text">HNK</p>
                        <p class="mnemonic-box__hint">Hareketsiz - Non-hemolitik - KapsÃ¼llÃ¼</p>
                    </div>
                `
            },
            {
                title: "SÄ±nav Ä°Ã§in Kritik Noktalar",
                icon: "fas fa-graduation-cap",
                content: `
                    <div class="highlight-box">
                        <p class="highlight-box__title">TUS/Yeterlilik Klasikleri</p>
                        <p class="highlight-box__content">
                            1. Antraks toksini <strong>PLAZMID (pXO1)</strong> kaynaklÄ±dÄ±r, faj deÄŸil!<br>
                            2. B. anthracis <strong>HAREKETSÄ°Z</strong> (diÄŸer Bacillus hareketli)<br>
                            3. Deri lezyonu <strong>AÄRISIZ</strong>, siyah eskar<br>
                            4. Pulmoner antraksta <strong>mediastinal geniÅŸleme</strong><br>
                            5. KapsÃ¼l <strong>protein yapÄ±da</strong> (poli-D-glutamik asit), polisakkarit deÄŸil!
                        </p>
                    </div>

                    <table class="article-table">
                        <tr>
                            <th>Ã–zellik</th>
                            <th>B. anthracis</th>
                            <th>B. cereus</th>
                        </tr>
                        <tr>
                            <td>Hareket</td>
                            <td><b>Hareketsiz</b></td>
                            <td>Hareketli</td>
                        </tr>
                        <tr>
                            <td>Hemoliz</td>
                            <td>Non-hemolitik</td>
                            <td><b>Î²-hemolitik</b></td>
                        </tr>
                        <tr>
                            <td>KapsÃ¼l</td>
                            <td><b>Var</b></td>
                            <td>Yok</td>
                        </tr>
                        <tr>
                            <td>Gamma faj</td>
                            <td>DuyarlÄ±</td>
                            <td>DirenÃ§li</td>
                        </tr>
                        <tr>
                            <td>Penisilin</td>
                            <td>DuyarlÄ±</td>
                            <td>DirenÃ§li</td>
                        </tr>
                    </table>

                    <ul class="feature-list">
                        <li class="feature-item"><b>Soru tipi:</b> "Spor oluÅŸturan, hareketsiz, kapsÃ¼llÃ¼ patojen?" â†’ B. anthracis</li>
                        <li class="feature-item"><b>Soru tipi:</b> "Siyah eskar + jelatinÃ¶z Ã¶dem?" â†’ Deri antraksi</li>
                        <li class="feature-item"><b>Soru tipi:</b> "Mediastinal geniÅŸleme + solunum sÄ±kÄ±ntÄ±sÄ±?" â†’ Pulmoner antraks</li>
                        <li class="feature-item"><b>Soru tipi:</b> "pXO1 ve pXO2 plazmidleri hangi bakteride?" â†’ B. anthracis</li>
                    </ul>
                `
            }
        ]
    },
    {
        id: 2,
        category: "viroloji",
        title: "OrtomiksovirÃ¼sler",
        subtitle: "Ä°nfluenza (Grip) VirÃ¼sleri",
        summary: "Segmentli, negatif iplikli RNA genomuna sahip, zarflÄ± virÃ¼slerdir. Antijenik shift ve drift mekanizmalarÄ±yla epidemi ve pandemilere neden olurlar. Ä°nfluenza A, B ve C tÃ¼rlerini iÃ§erir.",
        tags: ["RNA VirÃ¼sÃ¼", "Segmentli Genom", "ZarflÄ±", "Ä°nfluenza", "Pandemi", "Antijenik Varyasyon"],
        sections: [
            {
                title: "Genel Ã–zellikler",
                icon: "fas fa-virus",
                content: `
                    <p><strong>OrtomiksovirÃ¼sler</strong> (Orthomyxoviridae), solunum yolu enfeksiyonlarÄ±nÄ±n en Ã¶nemli viral etkenlerinden biridir. "Ortho" (dÃ¼z) ve "myxo" (mukus) kelimelerinden tÃ¼retilmiÅŸtir - mukus zarÄ±na afinitelerini yansÄ±tÄ±r.</p>
                    
                    <div class="highlight-box">
                        <p class="highlight-box__title">TanÄ±mlayÄ±cÄ± Ã–zellikler</p>
                        <p class="highlight-box__content">
                            <strong>Segmentli Genom:</strong> 7-8 segmentli negatif polariteli ssRNA genomu. Bu yapÄ± <strong>genetik reassortment (antijenik shift)</strong> iÃ§in temel oluÅŸturur ve pandemi potansiyeli yaratÄ±r.
                        </p>
                    </div>

                    <ul class="feature-list">
                        <li class="feature-item"><b>Genom:</b> (-) ssRNA, segmentli (Ä°nfluenza A ve B: 8 segment, Ä°nfluenza C: 7 segment)</li>
                        <li class="feature-item"><b>Boyut:</b> 80-120 nm, pleomorfik (yuvarlak veya filamentÃ¶z)</li>
                        <li class="feature-item"><b>Zarf:</b> Var - Konak hÃ¼cre membranÄ±ndan kÃ¶ken alÄ±r</li>
                        <li class="feature-item"><b>Replikasyon:</b> <strong>Ã‡EKIRDEKTE</strong> (RNA virÃ¼sleri iÃ§in istisna!)</li>
                        <li class="feature-item"><b>Simetri:</b> Helikal nÃ¼kleokapsid</li>
                    </ul>

                    <div class="alert-box alert-box--warning">
                        <span class="alert-box__icon">âš ï¸</span>
                        <p class="alert-box__text"><strong>Dikkat:</strong> Ä°nfluenza virÃ¼sÃ¼ Ã§ekirdekte replike olan nadir RNA virÃ¼slerindendir! DiÄŸerleri: RetrovirÃ¼sler, BornavirÃ¼s, Hepatit D. Ã‡oÄŸu RNA virÃ¼sÃ¼ sitoplazmada Ã§oÄŸalÄ±r.</p>
                    </div>
                `
            },
            {
                title: "YapÄ±sal Proteinler ve Antijenik YapÄ±",
                icon: "fas fa-dna",
                content: `
                    <p>VirÃ¼s yÃ¼zeyinde iki kritik glikoprotein bulunur. Bunlar hem virÃ¼lans hem de aÅŸÄ±/ilaÃ§ hedefi olarak Ã¶nemlidir:</p>

                    <table class="article-table">
                        <tr>
                            <th>Protein</th>
                            <th>Fonksiyon</th>
                            <th>Klinik Ã–nemi</th>
                        </tr>
                        <tr>
                            <td><b>HemaglÃ¼tinin (HA)</b></td>
                            <td>Sialik asit reseptÃ¶rÃ¼ne baÄŸlanma, membran fÃ¼zyonu</td>
                            <td>NÃ¶tralizan antikor hedefi, H1-H18 alt tipleri</td>
                        </tr>
                        <tr>
                            <td><b>NÃ¶raminidaz (NA)</b></td>
                            <td>Sialik asidi keser, virÃ¼s salÄ±nÄ±mÄ±, mukus penetrasyonu</td>
                            <td>Antiviral hedef (Oseltamivir), N1-N11 alt tipleri</td>
                        </tr>
                        <tr>
                            <td><b>M1 (Matriks)</b></td>
                            <td>Kapsid yapÄ±sÄ±, virÃ¼s tomurcuklanmasÄ±</td>
                            <td>En bol protein, tip spesifik antijen</td>
                        </tr>
                        <tr>
                            <td><b>M2 (Ä°yon kanalÄ±)</b></td>
                            <td>Proton kanalÄ±, uncoating iÃ§in pH dÃ¼ÅŸÃ¼rme</td>
                            <td>Amantadin hedefi (sadece Ä°nfluenza A)</td>
                        </tr>
                        <tr>
                            <td><b>NP (NÃ¼kleoprotein)</b></td>
                            <td>RNA'yÄ± sarar, tip spesifik</td>
                            <td>A, B, C ayrÄ±mÄ±nda kullanÄ±lÄ±r</td>
                        </tr>
                    </table>

                    <div class="sub-section">
                        <h4 class="sub-section__title">Ä°nfluenza TÃ¼rleri KarÅŸÄ±laÅŸtÄ±rmasÄ±</h4>
                        <table class="article-table">
                            <tr>
                                <th>Ã–zellik</th>
                                <th>Ä°nfluenza A</th>
                                <th>Ä°nfluenza B</th>
                                <th>Ä°nfluenza C</th>
                            </tr>
                            <tr>
                                <td>Konak</td>
                                <td>Ä°nsan, kuÅŸ, domuz, at, deniz memelileri</td>
                                <td>Sadece insan</td>
                                <td>Ä°nsan, domuz</td>
                            </tr>
                            <tr>
                                <td>Segment sayÄ±sÄ±</td>
                                <td>8</td>
                                <td>8</td>
                                <td>7</td>
                            </tr>
                            <tr>
                                <td>Antijenik shift</td>
                                <td><b>VAR (Pandemi!)</b></td>
                                <td>Yok</td>
                                <td>Yok</td>
                            </tr>
                            <tr>
                                <td>HastalÄ±k ÅŸiddeti</td>
                                <td>AÄŸÄ±r</td>
                                <td>Orta</td>
                                <td>Hafif</td>
                            </tr>
                            <tr>
                                <td>M2 proteini</td>
                                <td>Var</td>
                                <td>Yok (NB var)</td>
                                <td>Yok</td>
                            </tr>
                        </table>
                    </div>

                    <div class="highlight-box">
                        <p class="highlight-box__title">Antijen AdlandÄ±rma Sistemi</p>
                        <p class="highlight-box__content">
                            <strong>A/California/7/2009 (H1N1)</strong><br>
                            A = Tip | California = Ä°zolasyon yeri | 7 = SuÅŸ no | 2009 = YÄ±l | (H1N1) = Alt tip
                        </p>
                    </div>
                `
            },
            {
                title: "Antijenik Varyasyon MekanizmalarÄ±",
                icon: "fas fa-random",
                content: `
                    <p>Ä°nfluenza virÃ¼sÃ¼nÃ¼n sÃ¼rekli deÄŸiÅŸimi, tekrarlayan enfeksiyonlarÄ±n ve aÅŸÄ± gÃ¼ncellemelerinin temel nedenidir:</p>

                    <div class="sub-section">
                        <h4 class="sub-section__title">1. Antijenik Drift (Kayma)</h4>
                        <ul class="feature-list">
                            <li class="feature-item"><b>Mekanizma:</b> RNA polimerazÄ±n dÃ¼zeltme (proofreading) aktivitesinin olmamasÄ± â†’ Nokta mutasyonlar birikimi</li>
                            <li class="feature-item"><b>Etkilenen genler:</b> Ã–zellikle HA ve NA genleri</li>
                            <li class="feature-item"><b>SonuÃ§:</b> Mevcut antikorlardan kÄ±smi kaÃ§Ä±ÅŸ</li>
                            <li class="feature-item"><b>Epidemiyoloji:</b> YÄ±llÄ±k <strong>EPÄ°DEMÄ°LER</strong></li>
                            <li class="feature-item"><b>GÃ¶rÃ¼ldÃ¼ÄŸÃ¼ tipler:</b> Ä°nfluenza A ve B</li>
                        </ul>
                    </div>

                    <div class="sub-section">
                        <h4 class="sub-section__title">2. Antijenik Shift (SÄ±Ã§rama)</h4>
                        <ul class="feature-list">
                            <li class="feature-item"><b>Mekanizma:</b> FarklÄ± tÃ¼rlerden gelen virÃ¼slerin <strong>genetik reassortment</strong>'Ä± (segment deÄŸiÅŸimi)</li>
                            <li class="feature-item"><b>Gereksinim:</b> AynÄ± hÃ¼crede iki farklÄ± virÃ¼sÃ¼n ko-enfeksiyonu</li>
                            <li class="feature-item"><b>SonuÃ§:</b> Tamamen yeni HA veya NA alt tipi â†’ Toplumda baÄŸÄ±ÅŸÄ±klÄ±k yok</li>
                            <li class="feature-item"><b>Epidemiyoloji:</b> <strong>PANDEMÄ°LER</strong></li>
                            <li class="feature-item"><b>GÃ¶rÃ¼ldÃ¼ÄŸÃ¼ tipler:</b> <strong>SADECE Ä°nfluenza A</strong> (zoonotik rezervuar nedeniyle)</li>
                        </ul>
                    </div>

                    <div class="alert-box alert-box--info">
                        <span class="alert-box__icon">â„¹ï¸</span>
                        <p class="alert-box__text"><strong>SÄ±nav Notu:</strong> Shift = Segment deÄŸiÅŸimi = Sadece A = Pandemi<br>
                        Drift = Nokta mutasyon = A ve B = Epidemi<br>
                        <strong>"Shift" kelimesinde "S" harfi = "Segment" ve "Sadece A"</strong></p>
                    </div>

                    <div class="highlight-box">
                        <p class="highlight-box__title">Domuz "KarÄ±ÅŸtÄ±rma KabÄ±" (Mixing Vessel)</p>
                        <p class="highlight-box__content">
                            Domuz solunum epiteli hem Î±2,3 (kuÅŸ tipi) hem Î±2,6 (insan tipi) sialik asit reseptÃ¶rÃ¼ taÅŸÄ±r. Bu nedenle kuÅŸ ve insan virÃ¼sleri domuzda aynÄ± anda Ã§oÄŸalÄ±p reassortment yapabilir â†’ Yeni pandemik suÅŸlar!
                        </p>
                    </div>
                `
            },
            {
                title: "Replikasyon DÃ¶ngÃ¼sÃ¼",
                icon: "fas fa-sync-alt",
                content: `
                    <p>Ä°nfluenza virÃ¼sÃ¼nÃ¼n yaÅŸam dÃ¶ngÃ¼sÃ¼, antiviral ilaÃ§larÄ±n hedef noktalarÄ±nÄ± anlamak iÃ§in kritiktir:</p>

                    <div class="sub-section">
                        <h4 class="sub-section__title">Replikasyon BasamaklarÄ±</h4>
                        <ul class="feature-list">
                            <li class="feature-item"><b>1. Tutunma:</b> HA â†’ Sialik asit reseptÃ¶rÃ¼ (Î±2,6 insan, Î±2,3 kuÅŸ)</li>
                            <li class="feature-item"><b>2. GiriÅŸ:</b> ReseptÃ¶r aracÄ±lÄ± endositoz</li>
                            <li class="feature-item"><b>3. Uncoating:</b> M2 iyon kanalÄ± â†’ Endozom asidifikasyonu â†’ Viral RNA salÄ±nÄ±mÄ±</li>
                            <li class="feature-item"><b>4. Ã‡ekirdek transportu:</b> vRNP kompleksleri Ã§ekirdeÄŸe taÅŸÄ±nÄ±r</li>
                            <li class="feature-item"><b>5. Transkripsiyon/Replikasyon:</b> Viral RNA polimeraz (PB1, PB2, PA) Ã§ekirdekte Ã§alÄ±ÅŸÄ±r</li>
                            <li class="feature-item"><b>6. Protein sentezi:</b> mRNA â†’ Sitoplazmada translasyon</li>
                            <li class="feature-item"><b>7. Montaj:</b> YÃ¼zey proteinleri (HA, NA) Golgi'de glikozillenir</li>
                            <li class="feature-item"><b>8. Tomurcuklanma:</b> HÃ¼cre zarÄ±ndan Ã§Ä±kÄ±ÅŸ</li>
                            <li class="feature-item"><b>9. SalÄ±nÄ±m:</b> NA sialik asidi keser â†’ VirÃ¼s serbest kalÄ±r</li>
                        </ul>
                    </div>

                    <table class="article-table">
                        <tr>
                            <th>Basamak</th>
                            <th>Antiviral Ä°laÃ§</th>
                            <th>Not</th>
                        </tr>
                        <tr>
                            <td>Uncoating (M2)</td>
                            <td>Amantadin, Rimantadin</td>
                            <td>Sadece A, yaygÄ±n direnÃ§</td>
                        </tr>
                        <tr>
                            <td>SalÄ±nÄ±m (NA)</td>
                            <td>Oseltamivir, Zanamivir</td>
                            <td>A ve B, ilk seÃ§enek</td>
                        </tr>
                        <tr>
                            <td>Cap-snatching</td>
                            <td>Baloxavir marboxil</td>
                            <td>Yeni, tek doz</td>
                        </tr>
                    </table>

                    <div class="alert-box alert-box--warning">
                        <span class="alert-box__icon">âš ï¸</span>
                        <p class="alert-box__text"><strong>Cap-Snatching:</strong> Ä°nfluenza, konak mRNA'larÄ±ndan "cap" yapÄ±sÄ±nÄ± Ã§alar (cap-snatching). Bu viral mRNA sentezi iÃ§in gereklidir ve Ã§ekirdekte replikasyonun nedenlerinden biridir!</p>
                    </div>
                `
            },
            {
                title: "Klinik Tablolar",
                icon: "fas fa-user-injured",
                content: `
                    <p>Ä°nfluenza enfeksiyonu asemptomatikten Ã¶lÃ¼mcÃ¼le kadar geniÅŸ bir spektrumda seyredebilir:</p>

                    <div class="sub-section">
                        <h4 class="sub-section__title">Klasik Ä°nfluenza (Grip)</h4>
                        <ul class="feature-list">
                            <li class="feature-item"><b>Ä°nkÃ¼basyon:</b> 1-4 gÃ¼n (ortalama 2 gÃ¼n)</li>
                            <li class="feature-item"><b>BaÅŸlangÄ±Ã§:</b> ANÄ°, yÃ¼ksek ateÅŸ (39-41Â°C), titreme</li>
                            <li class="feature-item"><b>Sistemik:</b> Åiddetli miyalji, artralji, baÅŸ aÄŸrÄ±sÄ±, halsizlik, iÅŸtahsÄ±zlÄ±k</li>
                            <li class="feature-item"><b>Solunum:</b> Kuru Ã¶ksÃ¼rÃ¼k, boÄŸaz aÄŸrÄ±sÄ±, rinore, gÃ¶z yaÅŸarmasÄ±</li>
                            <li class="feature-item"><b>SÃ¼re:</b> AteÅŸ 3-5 gÃ¼n, Ã¶ksÃ¼rÃ¼k 2-3 hafta sÃ¼rebilir</li>
                        </ul>
                    </div>

                    <div class="highlight-box">
                        <p class="highlight-box__title">Grip vs. SoÄŸuk AlgÄ±nlÄ±ÄŸÄ±</p>
                        <p class="highlight-box__content">
                            <strong>Grip:</strong> Ani baÅŸlangÄ±Ã§, yÃ¼ksek ateÅŸ, ÅŸiddetli miyalji, yataÄŸa dÃ¼ÅŸÃ¼rÃ¼r<br>
                            <strong>SoÄŸuk algÄ±nlÄ±ÄŸÄ±:</strong> YavaÅŸ baÅŸlangÄ±Ã§, hafif ateÅŸ, rinore Ã¶n planda, gÃ¼nlÃ¼k aktivite devam eder
                        </p>
                    </div>

                    <div class="sub-section">
                        <h4 class="sub-section__title">Komplikasyonlar</h4>
                        <ul class="feature-list">
                            <li class="feature-item"><b>Primer viral pnÃ¶moni:</b> Nadir ama Ã¶lÃ¼mcÃ¼l, bilateral interstisyel infiltrasyon, ARDS geliÅŸebilir</li>
                            <li class="feature-item"><b>Sekonder bakteriyel pnÃ¶moni:</b> En sÄ±k komplikasyon. Etkenler: <strong>S. pneumoniae, S. aureus, H. influenzae</strong></li>
                            <li class="feature-item"><b>Reye sendromu:</b> Aspirinle birlikte â†’ Ensefalopati + KaraciÄŸer yaÄŸlanmasÄ± (Ã§ocuklarda)</li>
                            <li class="feature-item"><b>Miyokardit/Perikardit:</b> Nadir</li>
                            <li class="feature-item"><b>Ensefalit:</b> Nadir</li>
                            <li class="feature-item"><b>Guillain-BarrÃ© sendromu:</b> Post-enfeksiyÃ¶z</li>
                        </ul>
                    </div>

                    <div class="alert-box alert-box--danger">
                        <span class="alert-box__icon">ğŸš¨</span>
                        <p class="alert-box__text"><strong>Reye Sendromu:</strong> 18 yaÅŸ altÄ±nda grip veya suÃ§iÃ§eÄŸi + Aspirin kullanÄ±mÄ± â†’ Akut ensefalopati + MikrovezikÃ¼ler karaciÄŸer yaÄŸlanmasÄ±. <strong>Ã‡ocuklarda aspirin kontrendike!</strong></p>
                    </div>

                    <div class="sub-section">
                        <h4 class="sub-section__title">YÃ¼ksek Risk GruplarÄ±</h4>
                        <ul class="feature-list">
                            <li class="feature-item">65 yaÅŸ Ã¼stÃ¼, 2 yaÅŸ altÄ±</li>
                            <li class="feature-item">Gebeler (Ã¶zellikle 2. ve 3. trimester)</li>
                            <li class="feature-item">Kronik hastalÄ±klar (KOAH, astÄ±m, DM, kalp hastalÄ±ÄŸÄ±)</li>
                            <li class="feature-item">Ä°mmÃ¼nsÃ¼presifler</li>
                            <li class="feature-item">Morbid obezite (BMI â‰¥40)</li>
                            <li class="feature-item">BakÄ±mevi sakinleri</li>
                        </ul>
                    </div>
                `
            },
            {
                title: "Laboratuvar TanÄ±sÄ±",
                icon: "fas fa-flask",
                content: `
                    <p>TanÄ± klinik olarak konabilir ancak epidemiyolojik sÃ¼rveyans ve antiviral tedavi kararÄ± iÃ§in laboratuvar doÄŸrulamasÄ± Ã¶nemlidir:</p>

                    <table class="article-table">
                        <tr>
                            <th>YÃ¶ntem</th>
                            <th>Avantaj</th>
                            <th>Dezavantaj</th>
                        </tr>
                        <tr>
                            <td><b>HÄ±zlÄ± Antijen Testi (RIDT)</b></td>
                            <td>15-30 dk sonuÃ§, ucuz, kolay</td>
                            <td>DÃ¼ÅŸÃ¼k duyarlÄ±lÄ±k (%50-70)</td>
                        </tr>
                        <tr>
                            <td><b>RT-PCR</b></td>
                            <td>AltÄ±n standart, yÃ¼ksek duyarlÄ±lÄ±k/Ã¶zgÃ¼llÃ¼k, tiplendirme</td>
                            <td>PahalÄ±, uzun sÃ¼re, ekipman gerektirir</td>
                        </tr>
                        <tr>
                            <td><b>DFA (Direkt Floresan Antikor)</b></td>
                            <td>BirkaÃ§ saat, panel tarama</td>
                            <td>Deneyimli personel gerektirir</td>
                        </tr>
                        <tr>
                            <td><b>Viral KÃ¼ltÃ¼r</b></td>
                            <td>Referans standart, izolasyon</td>
                            <td>3-7 gÃ¼n, rutin tanÄ±da kullanÄ±lmaz</td>
                        </tr>
                        <tr>
                            <td><b>Seroloji</b></td>
                            <td>Retrospektif tanÄ±, epidemiyolojik Ã§alÄ±ÅŸmalar</td>
                            <td>Akut tanÄ±da faydasÄ±z (4 kat titre artÄ±ÅŸÄ± gerekir)</td>
                        </tr>
                    </table>

                    <div class="highlight-box">
                        <p class="highlight-box__title">Ã–rnek Alma</p>
                        <p class="highlight-box__content">
                            <strong>Optimal Ã¶rnek:</strong> Nazofaringeal sÃ¼rÃ¼ntÃ¼ veya aspirat<br>
                            <strong>Zamanlama:</strong> Semptom baÅŸlangÄ±cÄ±ndan sonraki ilk 3-4 gÃ¼n (viral yÃ¼k en yÃ¼ksek)<br>
                            <strong>Transport:</strong> Viral transport besiyerinde, +4Â°C'de
                        </p>
                    </div>

                    <ul class="feature-list">
                        <li class="feature-item"><b>HemaglÃ¼tinasyon Ä°nhibisyon (HAI):</b> Serotiplendirme iÃ§in referans yÃ¶ntem</li>
                        <li class="feature-item"><b>KÃ¼ltÃ¼r ortamÄ±:</b> MDCK hÃ¼creleri (kÃ¶pek bÃ¶brek), embriyonlu yumurta</li>
                        <li class="feature-item"><b>Sitopatik etki:</b> Belirgin deÄŸil, hemaglÃ¼tinasyon ile tespit edilir</li>
                    </ul>
                `
            },
            {
                title: "Tedavi",
                icon: "fas fa-pills",
                content: `
                    <p>Antiviral tedavi <strong>semptom baÅŸlangÄ±cÄ±ndan sonraki 48 saat iÃ§inde</strong> baÅŸlanÄ±rsa en etkilidir:</p>

                    <div class="sub-section">
                        <h4 class="sub-section__title">NÃ¶raminidaz Ä°nhibitÃ¶rleri (Ä°lk SeÃ§enek)</h4>
                        <ul class="feature-list">
                            <li class="feature-item"><b>Oseltamivir (Tamiflu):</b> Oral, 75 mg 2x1, 5 gÃ¼n. Ã‡ocuklarda ve gebelerde kullanÄ±labilir</li>
                            <li class="feature-item"><b>Zanamivir (Relenza):</b> Ä°nhaler, 10 mg 2x1, 5 gÃ¼n. AstÄ±m/KOAH'ta dikkatli</li>
                            <li class="feature-item"><b>Peramivir:</b> IV, tek doz. Hospitalize hastalarda</li>
                            <li class="feature-item"><b>Etki:</b> Ä°nfluenza A ve B'ye etkili</li>
                            <li class="feature-item"><b>Mekanizma:</b> NA enzimini inhibe eder â†’ VirÃ¼s hÃ¼creden Ã§Ä±kamaz</li>
                        </ul>
                    </div>

                    <div class="sub-section">
                        <h4 class="sub-section__title">M2 Ä°nhibitÃ¶rleri (ArtÄ±k Ã–nerilmez)</h4>
                        <ul class="feature-list">
                            <li class="feature-item"><b>Amantadin, Rimantadin:</b> Sadece Ä°nfluenza A'ya etkili</li>
                            <li class="feature-item"><b>Mekanizma:</b> M2 iyon kanalÄ±nÄ± bloke eder â†’ Uncoating engellenir</li>
                            <li class="feature-item"><b>Sorun:</b> YaygÄ±n direnÃ§ (>%99), Ä°nfluenza B'ye etkisiz</li>
                            <li class="feature-item"><b>Yan etkiler:</b> SSS toksisitesi (amantadin)</li>
                        </ul>
                    </div>

                    <div class="sub-section">
                        <h4 class="sub-section__title">Yeni Antiviraller</h4>
                        <ul class="feature-list">
                            <li class="feature-item"><b>Baloxavir marboxil (Xofluza):</b> Cap-baÄŸÄ±mlÄ± endonÃ¼kleaz inhibitÃ¶rÃ¼. Tek doz oral. A ve B'ye etkili</li>
                            <li class="feature-item"><b>Favipiravir:</b> RNA polimeraz inhibitÃ¶rÃ¼, geniÅŸ spektrum</li>
                        </ul>
                    </div>

                    <div class="alert-box alert-box--info">
                        <span class="alert-box__icon">â„¹ï¸</span>
                        <p class="alert-box__text"><strong>Tedavi EndikasyonlarÄ±:</strong><br>
                        â€¢ Hospitalize hastalar<br>
                        â€¢ AÄŸÄ±r veya komplike grip<br>
                        â€¢ YÃ¼ksek risk gruplarÄ±<br>
                        â€¢ 48 saat iÃ§inde baÅŸvuran tÃ¼m doÄŸrulanmÄ±ÅŸ vakalar</p>
                    </div>
                `
            },
            {
                title: "Korunma ve AÅŸÄ±lama",
                icon: "fas fa-shield-virus",
                content: `
                    <p>Ä°nfluenza aÅŸÄ±sÄ± her yÄ±l gÃ¼ncellenir ve en etkili korunma yÃ¶ntemidir:</p>

                    <div class="sub-section">
                        <h4 class="sub-section__title">AÅŸÄ± Tipleri</h4>
                        <table class="article-table">
                            <tr>
                                <th>AÅŸÄ± Tipi</th>
                                <th>Ã–zellik</th>
                                <th>Uygulama</th>
                            </tr>
                            <tr>
                                <td><b>IIV (Ä°naktive)</b></td>
                                <td>Ã–lÃ¼ virÃ¼s, en yaygÄ±n</td>
                                <td>IM, 6 ay Ã¼stÃ¼ herkese</td>
                            </tr>
                            <tr>
                                <td><b>LAIV (CanlÄ± AtenÃ¼e)</b></td>
                                <td>SoÄŸuÄŸa adapte, zayÄ±flatÄ±lmÄ±ÅŸ</td>
                                <td>Ä°ntranazal, 2-49 yaÅŸ saÄŸlÄ±klÄ± bireyler</td>
                            </tr>
                            <tr>
                                <td><b>Rekombinant (RIV)</b></td>
                                <td>Yumurta iÃ§ermez</td>
                                <td>Yumurta alerjisinde</td>
                            </tr>
                            <tr>
                                <td><b>YÃ¼ksek Doz IIV</b></td>
                                <td>4x antijen iÃ§erir</td>
                                <td>65 yaÅŸ Ã¼stÃ¼</td>
                            </tr>
                        </table>
                    </div>

                    <div class="highlight-box">
                        <p class="highlight-box__title">AÅŸÄ± Ä°Ã§eriÄŸi (2024-2025 Ã–rnek)</p>
                        <p class="highlight-box__content">
                            <strong>Kuadrivalan:</strong> 2 Ä°nfluenza A (H1N1 ve H3N2) + 2 Ä°nfluenza B (Victoria ve Yamagata soylarÄ±)<br>
                            Her yÄ±l DSÃ– Ã¶nerisiyle gÃ¼ncellenir (Kuzey yarÄ±mkÃ¼re: Åubat, GÃ¼ney: EylÃ¼l)
                        </p>
                    </div>

                    <div class="sub-section">
                        <h4 class="sub-section__title">AÅŸÄ± KontrendikasyonlarÄ±</h4>
                        <ul class="feature-list">
                            <li class="feature-item">AÅŸÄ± bileÅŸenlerine ciddi alerjik reaksiyon Ã¶ykÃ¼sÃ¼</li>
                            <li class="feature-item"><b>LAIV kontrendike:</b> Gebeler, immÃ¼nsÃ¼presifler, 2 yaÅŸ altÄ±, astÄ±mlÄ±lar, aspirin kullanan Ã§ocuklar</li>
                            <li class="feature-item">AÄŸÄ±r yumurta alerjisinde: Rekombinant aÅŸÄ± veya tÄ±bbi gÃ¶zetimde IIV</li>
                        </ul>
                    </div>

                    <div class="sub-section">
                        <h4 class="sub-section__title">Kemoprofilaksi</h4>
                        <ul class="feature-list">
                            <li class="feature-item"><b>Ä°ndikasyon:</b> AÅŸÄ± kontrendike veya yetersiz kaldÄ±ÄŸÄ±nda temas sonrasÄ±</li>
                            <li class="feature-item"><b>Ä°laÃ§:</b> Oseltamivir 75 mg 1x1, 7-10 gÃ¼n veya temas sÃ¼resince</li>
                            <li class="feature-item"><b>Zanamivir:</b> 10 mg 1x1 inhaler, alternatif</li>
                        </ul>
                    </div>

                    <div class="alert-box alert-box--warning">
                        <span class="alert-box__icon">âš ï¸</span>
                        <p class="alert-box__text"><strong>LAIV (CanlÄ± aÅŸÄ±):</strong> CanlÄ± virÃ¼s iÃ§erdiÄŸinden immÃ¼nsÃ¼presif hastalara, gebelere ve 2 yaÅŸ altÄ±na <strong>KESÄ°NLÄ°KLE YAPILMAZ!</strong> Ä°naktif aÅŸÄ± (IIV) bu gruplarda tercih edilir.</p>
                    </div>
                `
            },
            {
                title: "Epidemiyoloji ve Pandemiler",
                icon: "fas fa-globe",
                content: `
                    <p>Ä°nfluenza, insanlÄ±k tarihinin en yÄ±kÄ±cÄ± pandemilerine neden olmuÅŸtur:</p>

                    <div class="sub-section">
                        <h4 class="sub-section__title">Ã–nemli Pandemiler</h4>
                        <table class="article-table">
                            <tr>
                                <th>Pandemi</th>
                                <th>YÄ±l</th>
                                <th>Alt Tip</th>
                                <th>Ã–lÃ¼m</th>
                            </tr>
                            <tr>
                                <td><b>Ä°spanyol Gribi</b></td>
                                <td>1918-1919</td>
                                <td>H1N1</td>
                                <td>50-100 milyon</td>
                            </tr>
                            <tr>
                                <td><b>Asya Gribi</b></td>
                                <td>1957-1958</td>
                                <td>H2N2</td>
                                <td>1-2 milyon</td>
                            </tr>
                            <tr>
                                <td><b>Hong Kong Gribi</b></td>
                                <td>1968-1969</td>
                                <td>H3N2</td>
                                <td>1 milyon</td>
                            </tr>
                            <tr>
                                <td><b>Domuz Gribi</b></td>
                                <td>2009-2010</td>
                                <td>H1N1pdm09</td>
                                <td>~284.000</td>
                            </tr>
                        </table>
                    </div>

                    <div class="highlight-box">
                        <p class="highlight-box__title">KuÅŸ Gribi Tehdidi</p>
                        <p class="highlight-box__content">
                            <strong>H5N1:</strong> YÃ¼ksek mortalite (%60), sÄ±nÄ±rlÄ± insan-insan bulaÅŸÄ±<br>
                            <strong>H7N9:</strong> Ã‡in'de sporadik vakalar, pandemi potansiyeli<br>
                            KuÅŸ â†’ Ä°nsan bulaÅŸÄ± olur ancak etkin insan-insan bulaÅŸÄ± iÃ§in mutasyon gerekir
                        </p>
                    </div>

                    <ul class="feature-list">
                        <li class="feature-item"><b>Mevsimsel daÄŸÄ±lÄ±m:</b> Kuzey yarÄ±mkÃ¼rede KasÄ±m-Mart, gÃ¼neyde MayÄ±s-EylÃ¼l</li>
                        <li class="feature-item"><b>BulaÅŸ:</b> DamlacÄ±k (>5 Î¼m, 1-2 m), aerosol (<5 Î¼m), temas</li>
                        <li class="feature-item"><b>BulaÅŸtÄ±rÄ±cÄ±lÄ±k:</b> Semptom baÅŸlangÄ±cÄ±ndan 1 gÃ¼n Ã¶nce - 5-7 gÃ¼n sonra</li>
                        <li class="feature-item"><b>R0 (Mevsimsel):</b> 1.2-1.4</li>
                        <li class="feature-item"><b>R0 (Pandemik):</b> 1.5-2.5</li>
                    </ul>

                    <div class="mnemonic-box">
                        <p class="mnemonic-box__label">Pandemi ÅartlarÄ±</p>
                        <p class="mnemonic-box__text">YEB</p>
                        <p class="mnemonic-box__hint">Yeni alt tip - Etkin insan-insan bulaÅŸÄ± - BaÄŸÄ±ÅŸÄ±klÄ±k yok</p>
                    </div>
                `
            },
            {
                title: "SÄ±nav Ä°Ã§in Kritik Noktalar",
                icon: "fas fa-graduation-cap",
                content: `
                    <div class="highlight-box">
                        <p class="highlight-box__title">TUS/Yeterlilik Klasikleri</p>
                        <p class="highlight-box__content">
                            1. <strong>Segmentli genom</strong> â†’ Reassortment â†’ Shift â†’ Pandemi<br>
                            2. <strong>Ã‡ekirdekte replikasyon</strong> yapan RNA virÃ¼sÃ¼!<br>
                            3. Shift <strong>sadece Ä°nfluenza A</strong>'da gÃ¶rÃ¼lÃ¼r<br>
                            4. <strong>Domuz = Mixing vessel</strong> (karÄ±ÅŸtÄ±rma kabÄ±)<br>
                            5. M2 proteini <strong>sadece Ä°nfluenza A</strong>'da var<br>
                            6. <strong>Reye sendromu:</strong> Grip/SuÃ§iÃ§eÄŸi + Aspirin (Ã§ocuk)<br>
                            7. Sekonder bakteriyel pnÃ¶moni: <strong>S. aureus, S. pneumoniae</strong>
                        </p>
                    </div>

                    <table class="article-table">
                        <tr>
                            <th>KarÅŸÄ±laÅŸtÄ±rma</th>
                            <th>Drift</th>
                            <th>Shift</th>
                        </tr>
                        <tr>
                            <td>Mekanizma</td>
                            <td>Nokta mutasyon</td>
                            <td>Reassortment</td>
                        </tr>
                        <tr>
                            <td>HÄ±z</td>
                            <td>Kademeli</td>
                            <td>Ani</td>
                        </tr>
                        <tr>
                            <td>SonuÃ§</td>
                            <td>Epidemi</td>
                            <td><b>Pandemi</b></td>
                        </tr>
                        <tr>
                            <td>Tipler</td>
                            <td>A ve B</td>
                            <td><b>Sadece A</b></td>
                        </tr>
                    </table>

                    <ul class="feature-list">
                        <li class="feature-item"><b>Soru tipi:</b> "Segmentli genom, zarflÄ±, Ã§ekirdekte Ã§oÄŸalan RNA virÃ¼sÃ¼?" â†’ Ä°nfluenza</li>
                        <li class="feature-item"><b>Soru tipi:</b> "Grip sonrasÄ± S. aureus pnÃ¶monisi?" â†’ Sekonder bakteriyel pnÃ¶moni</li>
                        <li class="feature-item"><b>Soru tipi:</b> "Antijenik shift ile pandemi yapan virÃ¼s?" â†’ Ä°nfluenza A</li>
                        <li class="feature-item"><b>Soru tipi:</b> "Amantadin hangi virÃ¼se etkili?" â†’ Sadece Ä°nfluenza A (M2 proteini)</li>
                        <li class="feature-item"><b>Soru tipi:</b> "Oseltamivir hedefi?" â†’ NÃ¶raminidaz</li>
                        <li class="feature-item"><b>Soru tipi:</b> "Ã‡ocukta grip + aspirin sonrasÄ± ensefalopati?" â†’ Reye sendromu</li>
                    </ul>
                `
            }
        ]
    },
    {
        id: 3,
        category: "bakteriyoloji",
        title: "Streptococcus agalactiae",
        subtitle: "Grup B Streptokok (GBS)",
        summary: "Î²-hemolitik, Lancefield Grup B antijeni taÅŸÄ±yan, Gram pozitif kok. YenidoÄŸan sepsis ve menenjitinin en sÄ±k etkeni olup, gebelikte tarama ve intrapartum profilaksi ile Ã¶nlenebilir.",
        tags: ["Gram Pozitif", "Î²-Hemolitik", "YenidoÄŸan Sepsis", "GBS", "CAMP Testi"],
        sections: [
            {
                title: "Genel Ã–zellikler",
                icon: "fas fa-microscope",
                content: `
                    <p><strong>Streptococcus agalactiae</strong>, Lancefield sÄ±nÄ±flamasÄ±nda <strong>Grup B</strong> antijeni taÅŸÄ±yan, Î²-hemolitik streptokoktur. Ã–zellikle yenidoÄŸan enfeksiyonlarÄ±ndaki rolÃ¼ nedeniyle klinik Ã¶nemi bÃ¼yÃ¼ktÃ¼r.</p>
                    
                    <div class="highlight-box">
                        <p class="highlight-box__title">TanÄ±mlayÄ±cÄ± Ã–zellikler</p>
                        <p class="highlight-box__content">
                            <strong>CAMP Testi Pozitif:</strong> S. aureus'un Î²-hemolizini ile sinerjistik etki â†’ Ok ucu ÅŸeklinde hemoliz. GBS tanÄ±sÄ±nda patognomonik test!
                        </p>
                    </div>

                    <ul class="feature-list">
                        <li class="feature-item"><b>Morfoloji:</b> Gram pozitif kok, zincir oluÅŸturur</li>
                        <li class="feature-item"><b>Hemoliz:</b> Î²-hemolitik (tam hemoliz, berrak zon)</li>
                        <li class="feature-item"><b>Lancefield grubu:</b> Grup B (hÃ¼cre duvarÄ± karbonhidrat antijeni)</li>
                        <li class="feature-item"><b>Katalaz:</b> Negatif (tÃ¼m streptokoklar gibi)</li>
                        <li class="feature-item"><b>Oksidaz:</b> Negatif</li>
                        <li class="feature-item"><b>FakÃ¼ltatif anaerob:</b> Evet</li>
                    </ul>

                    <div class="alert-box alert-box--info">
                        <span class="alert-box__icon">â„¹ï¸</span>
                        <p class="alert-box__text"><strong>Kolonizasyon:</strong> SaÄŸlÄ±klÄ± kadÄ±nlarÄ±n %15-30'unda vajinal ve rektal kolonizasyon bulunur. Asemptomatik taÅŸÄ±yÄ±cÄ±lÄ±k klinik aÃ§Ä±dan Ã¶nemlidir!</p>
                    </div>
                `
            },
            {
                title: "VirÃ¼lans FaktÃ¶rleri",
                icon: "fas fa-biohazard",
                content: `
                    <p>GBS'nin patogenezi Ã§eÅŸitli virÃ¼lans faktÃ¶rlerine baÄŸlÄ±dÄ±r:</p>

                    <table class="article-table">
                        <tr>
                            <th>VirÃ¼lans FaktÃ¶rÃ¼</th>
                            <th>Fonksiyon</th>
                            <th>Klinik Ã–nemi</th>
                        </tr>
                        <tr>
                            <td><b>Polisakkarit KapsÃ¼l</b></td>
                            <td>Antifagositik, kompleman inhibisyonu</td>
                            <td>Ana virÃ¼lans faktÃ¶rÃ¼, serotiplendirmede kullanÄ±lÄ±r (Ia, Ib, II-IX)</td>
                        </tr>
                        <tr>
                            <td><b>C5a Peptidaz</b></td>
                            <td>Kompleman C5a'yÄ± parÃ§alar</td>
                            <td>NÃ¶trofil kemotaksisini engeller</td>
                        </tr>
                        <tr>
                            <td><b>Î²-Hemolizin/Sitoalizin</b></td>
                            <td>HÃ¼cre lizisi, pigment Ã¼retimi</td>
                            <td>Doku hasarÄ±, CAMP faktÃ¶rÃ¼</td>
                        </tr>
                        <tr>
                            <td><b>Sialik Asit</b></td>
                            <td>MolekÃ¼ler benzerlik (mimetizm)</td>
                            <td>Ä°mmÃ¼n kaÃ§Ä±ÅŸ</td>
                        </tr>
                        <tr>
                            <td><b>Pili (Fimbriae)</b></td>
                            <td>Epitel hÃ¼crelere tutunma</td>
                            <td>Kolonizasyon</td>
                        </tr>
                    </table>

                    <div class="highlight-box">
                        <p class="highlight-box__title">Serotiplendirme</p>
                        <p class="highlight-box__content">
                            KapsÃ¼ler polisakkarite gÃ¶re 10 serotip: <strong>Ia, Ib, II, III, IV, V, VI, VII, VIII, IX</strong><br>
                            <strong>Serotip III:</strong> YenidoÄŸan menenjitinin en sÄ±k etkeni!<br>
                            <strong>Serotip V:</strong> EriÅŸkin invaziv enfeksiyonlarda sÄ±k
                        </p>
                    </div>

                    <div class="alert-box alert-box--warning">
                        <span class="alert-box__icon">âš ï¸</span>
                        <p class="alert-box__text"><strong>CAMP FaktÃ¶rÃ¼:</strong> GBS'nin Ã¼rettiÄŸi protein, S. aureus'un sfingomyelinaz C'si (Î²-toksin) ile sinerjistik etki gÃ¶sterir. Bu etkileÅŸim CAMP testinin temelini oluÅŸturur.</p>
                    </div>
                `
            },
            {
                title: "Klinik Tablolar - YenidoÄŸan",
                icon: "fas fa-baby",
                content: `
                    <p>GBS, yenidoÄŸan dÃ¶neminde iki farklÄ± klinik tablo ile karÅŸÄ±mÄ±za Ã§Ä±kar:</p>

                    <div class="sub-section">
                        <h4 class="sub-section__title">1. Erken BaÅŸlangÄ±Ã§lÄ± HastalÄ±k (Early-Onset Disease)</h4>
                        <ul class="feature-list">
                            <li class="feature-item"><b>Zamanlama:</b> DoÄŸumdan sonraki ilk 7 gÃ¼n iÃ§inde (genellikle ilk 24-48 saat)</li>
                            <li class="feature-item"><b>BulaÅŸ:</b> Vertikal (doÄŸum kanalÄ±ndan geÃ§iÅŸ sÄ±rasÄ±nda)</li>
                            <li class="feature-item"><b>Klinik:</b> Sepsis, pnÃ¶moni, menenjit</li>
                            <li class="feature-item"><b>Mortalite:</b> %5-10 (tedavi ile)</li>
                            <li class="feature-item"><b>Risk faktÃ¶rleri:</b> PrematÃ¼rite, uzamÄ±ÅŸ membran rÃ¼ptÃ¼rÃ¼ (>18 saat), maternal GBS kolonizasyonu, intrapartum ateÅŸ</li>
                        </ul>
                    </div>

                    <div class="sub-section">
                        <h4 class="sub-section__title">2. GeÃ§ BaÅŸlangÄ±Ã§lÄ± HastalÄ±k (Late-Onset Disease)</h4>
                        <ul class="feature-list">
                            <li class="feature-item"><b>Zamanlama:</b> 7 gÃ¼n - 3 ay arasÄ±</li>
                            <li class="feature-item"><b>BulaÅŸ:</b> Horizontal (hastane, toplum, anne)</li>
                            <li class="feature-item"><b>Klinik:</b> <strong>Menenjit</strong> daha sÄ±k (serotip III)</li>
                            <li class="feature-item"><b>Mortalite:</b> %2-6</li>
                            <li class="feature-item"><b>Sekel:</b> Ä°ÅŸitme kaybÄ±, nÃ¶rolojik hasar (%25-50)</li>
                        </ul>
                    </div>

                    <div class="alert-box alert-box--danger">
                        <span class="alert-box__icon">ğŸš¨</span>
                        <p class="alert-box__text"><strong>Kritik:</strong> GBS, yenidoÄŸan dÃ¶neminde <strong>bakteriyel sepsis ve menenjitin en sÄ±k etkenidir!</strong> Erken tanÄ± ve tedavi hayat kurtarÄ±cÄ±dÄ±r.</p>
                    </div>

                    <table class="article-table">
                        <tr>
                            <th>Ã–zellik</th>
                            <th>Erken BaÅŸlangÄ±Ã§</th>
                            <th>GeÃ§ BaÅŸlangÄ±Ã§</th>
                        </tr>
                        <tr>
                            <td>Zaman</td>
                            <td>0-7 gÃ¼n</td>
                            <td>7 gÃ¼n - 3 ay</td>
                        </tr>
                        <tr>
                            <td>BulaÅŸ</td>
                            <td>Vertikal</td>
                            <td>Horizontal</td>
                        </tr>
                        <tr>
                            <td>Ana klinik</td>
                            <td>Sepsis, pnÃ¶moni</td>
                            <td><b>Menenjit</b></td>
                        </tr>
                        <tr>
                            <td>Ã–nlenebilir mi?</td>
                            <td><b>Evet (IAP)</b></td>
                            <td>HayÄ±r</td>
                        </tr>
                    </table>
                `
            },
            {
                title: "Klinik Tablolar - EriÅŸkin ve Gebeler",
                icon: "fas fa-user-injured",
                content: `
                    <p>GBS sadece yenidoÄŸanlarda deÄŸil, gebelerde ve eriÅŸkinlerde de ciddi enfeksiyonlara neden olabilir:</p>

                    <div class="sub-section">
                        <h4 class="sub-section__title">Gebelerde GBS EnfeksiyonlarÄ±</h4>
                        <ul class="feature-list">
                            <li class="feature-item"><b>Asemptomatik bakteriÃ¼ri:</b> En sÄ±k, tarama ile saptanÄ±r</li>
                            <li class="feature-item"><b>Ãœriner sistem enfeksiyonu:</b> Sistit, piyelonefrit</li>
                            <li class="feature-item"><b>Koryoamnionit:</b> Ä°ntrauterin enfeksiyon</li>
                            <li class="feature-item"><b>Endometrit:</b> Postpartum</li>
                            <li class="feature-item"><b>Bakteriyemi:</b> Nadiren</li>
                        </ul>
                    </div>

                    <div class="sub-section">
                        <h4 class="sub-section__title">EriÅŸkinlerde (Gebe Olmayan)</h4>
                        <ul class="feature-list">
                            <li class="feature-item"><b>Risk gruplarÄ±:</b> Diyabet, kanser, karaciÄŸer hastalÄ±ÄŸÄ±, immÃ¼nsÃ¼presyon, >65 yaÅŸ</li>
                            <li class="feature-item"><b>Deri ve yumuÅŸak doku:</b> SelÃ¼lit, apse, nekrotizan fasiit (nadir)</li>
                            <li class="feature-item"><b>Kemik ve eklem:</b> Osteomiyelit, septik artrit</li>
                            <li class="feature-item"><b>Bakteriyemi:</b> Primer veya sekonder</li>
                            <li class="feature-item"><b>PnÃ¶moni:</b> Ã–zellikle yaÅŸlÄ±larda</li>
                            <li class="feature-item"><b>Endokardit:</b> Nadir ama ciddi</li>
                        </ul>
                    </div>

                    <div class="highlight-box">
                        <p class="highlight-box__title">Artmakta Olan Sorun</p>
                        <p class="highlight-box__content">
                            EriÅŸkin invaziv GBS enfeksiyonlarÄ± son yÄ±llarda artmaktadÄ±r. Ã–zellikle <strong>diyabetik ayak enfeksiyonlarÄ±</strong> ve <strong>yaÅŸlÄ±larda bakteriyemi</strong> Ã¶nemli klinik tablolardÄ±r.
                        </p>
                    </div>
                `
            },
            {
                title: "Laboratuvar TanÄ±sÄ±",
                icon: "fas fa-flask",
                content: `
                    <p>GBS tanÄ±sÄ±nda Ã§eÅŸitli laboratuvar yÃ¶ntemleri kullanÄ±lÄ±r:</p>

                    <table class="article-table">
                        <tr>
                            <th>YÃ¶ntem</th>
                            <th>SonuÃ§</th>
                            <th>KullanÄ±m</th>
                        </tr>
                        <tr>
                            <td><b>Gram boyama</b></td>
                            <td>Gram (+) koklar, zincir</td>
                            <td>HÄ±zlÄ± Ã¶n tanÄ±</td>
                        </tr>
                        <tr>
                            <td><b>KanlÄ± agar kÃ¼ltÃ¼rÃ¼</b></td>
                            <td>Î²-hemoliz (dar zon)</td>
                            <td>AltÄ±n standart</td>
                        </tr>
                        <tr>
                            <td><b>CAMP testi</b></td>
                            <td><strong>POZÄ°TÄ°F</strong> (ok ucu hemoliz)</td>
                            <td>TanÄ±sal, S. aureus ile</td>
                        </tr>
                        <tr>
                            <td><b>HipÃ¼rat hidrolizi</b></td>
                            <td><strong>POZÄ°TÄ°F</strong></td>
                            <td>DiÄŸer Î²-hemolitiklerden ayÄ±rÄ±m</td>
                        </tr>
                        <tr>
                            <td><b>Basitrasin duyarlÄ±lÄ±ÄŸÄ±</b></td>
                            <td><strong>DÄ°RENÃ‡LÄ°</strong></td>
                            <td>GAS'tan ayÄ±rÄ±m (GAS duyarlÄ±)</td>
                        </tr>
                        <tr>
                            <td><b>Lateks aglÃ¼tinasyon</b></td>
                            <td>Grup B antijeni (+)</td>
                            <td>HÄ±zlÄ± gruplama</td>
                        </tr>
                        <tr>
                            <td><b>Kromojenik agar</b></td>
                            <td>Renkli koloniler</td>
                            <td>Tarama kolaylÄ±ÄŸÄ±</td>
                        </tr>
                        <tr>
                            <td><b>PCR (NAAT)</b></td>
                            <td>GBS DNA</td>
                            <td>HÄ±zlÄ± intrapartum tarama</td>
                        </tr>
                    </table>

                    <div class="highlight-box">
                        <p class="highlight-box__title">CAMP Testi ProsedÃ¼rÃ¼</p>
                        <p class="highlight-box__content">
                            Koyun kanlÄ± agarda S. aureus Ã§izgisine dik olarak GBS Ã§izilir. 37Â°C'de inkÃ¼basyondan sonra kesiÅŸim noktasÄ±nda <strong>ok baÅŸÄ± ÅŸeklinde</strong> geniÅŸlemiÅŸ hemoliz zonu gÃ¶rÃ¼lÃ¼r. Bu sinerjistik hemoliz GBS iÃ§in karakteristiktir.
                        </p>
                    </div>

                    <div class="alert-box alert-box--info">
                        <span class="alert-box__icon">â„¹ï¸</span>
                        <p class="alert-box__text"><strong>Tarama Ã–rneÄŸi:</strong> Vajinal ve rektal sÃ¼rÃ¼ntÃ¼ birlikte alÄ±nmalÄ± (vajino-rektal sÃ¼rÃ¼ntÃ¼). Tek baÅŸÄ±na vajinal sÃ¼rÃ¼ntÃ¼ kolonizasyonun %10-20'sini kaÃ§Ä±rÄ±r!</p>
                    </div>
                `
            },
            {
                title: "Tedavi",
                icon: "fas fa-pills",
                content: `
                    <p>GBS enfeksiyonlarÄ±nda <strong>penisilin</strong> ilk seÃ§enek tedavidir:</p>

                    <div class="sub-section">
                        <h4 class="sub-section__title">Antibiyotik Tedavisi</h4>
                        <ul class="feature-list">
                            <li class="feature-item"><b>Ä°lk seÃ§enek:</b> Penisilin G (IV)</li>
                            <li class="feature-item"><b>Alternatif:</b> Ampisilin</li>
                            <li class="feature-item"><b>Penisilin alerjisi:</b> Sefazolin (dÃ¼ÅŸÃ¼k risk), Klindamisin veya Vankomisin (yÃ¼ksek risk)</li>
                            <li class="feature-item"><b>Menenjit:</b> YÃ¼ksek doz Penisilin G veya Ampisilin (Â± Gentamisin sinerjisi)</li>
                        </ul>
                    </div>

                    <div class="sub-section">
                        <h4 class="sub-section__title">DirenÃ§ Durumu</h4>
                        <ul class="feature-list">
                            <li class="feature-item"><b>Penisilin:</b> DirenÃ§ bildirilmemiÅŸ (MIC artÄ±ÅŸÄ± nadiren)</li>
                            <li class="feature-item"><b>Eritromisin:</b> %25-35 direnÃ§</li>
                            <li class="feature-item"><b>Klindamisin:</b> %15-25 direnÃ§</li>
                            <li class="feature-item"><b>Vankomisin:</b> DirenÃ§ yok</li>
                        </ul>
                    </div>

                    <table class="article-table">
                        <tr>
                            <th>Klinik Tablo</th>
                            <th>Tedavi</th>
                            <th>SÃ¼re</th>
                        </tr>
                        <tr>
                            <td>Neonatal sepsis</td>
                            <td>Ampisilin + Gentamisin</td>
                            <td>10-14 gÃ¼n</td>
                        </tr>
                        <tr>
                            <td>Neonatal menenjit</td>
                            <td>Ampisilin (yÃ¼ksek doz)</td>
                            <td>Minimum 14-21 gÃ¼n</td>
                        </tr>
                        <tr>
                            <td>EriÅŸkin bakteriyemi</td>
                            <td>Penisilin G</td>
                            <td>10-14 gÃ¼n</td>
                        </tr>
                        <tr>
                            <td>Osteomiyelit</td>
                            <td>Penisilin G</td>
                            <td>4-6 hafta</td>
                        </tr>
                    </table>

                    <div class="alert-box alert-box--warning">
                        <span class="alert-box__icon">âš ï¸</span>
                        <p class="alert-box__text"><strong>Ã–nemli:</strong> Penisilin alerjisi Ã¶ykÃ¼sÃ¼ varsa, alerji tipi sorgulanmalÄ±. IgE aracÄ±lÄ± (anafilaksi) deÄŸilse sefazolin gÃ¼venle kullanÄ±labilir. Belirsiz veya ciddi alerjide duyarlÄ±lÄ±k testine gÃ¶re klindamisin veya vankomisin tercih edilir.</p>
                    </div>
                `
            },
            {
                title: "Korunma - Ä°ntrapartum Antibiyotik Profilaksisi (IAP)",
                icon: "fas fa-shield-virus",
                content: `
                    <p>Erken baÅŸlangÄ±Ã§lÄ± GBS hastalÄ±ÄŸÄ±, <strong>intrapartum antibiyotik profilaksisi (IAP)</strong> ile Ã¶nlenebilir:</p>

                    <div class="sub-section">
                        <h4 class="sub-section__title">Tarama Stratejisi</h4>
                        <ul class="feature-list">
                            <li class="feature-item"><b>Zamanlama:</b> 36-37. gebelik haftasÄ±nda (eski: 35-37 hafta)</li>
                            <li class="feature-item"><b>Ã–rnek:</b> Vajino-rektal sÃ¼rÃ¼ntÃ¼</li>
                            <li class="feature-item"><b>YÃ¶ntem:</b> KÃ¼ltÃ¼r (altÄ±n standart) veya NAAT (hÄ±zlÄ± sonuÃ§)</li>
                            <li class="feature-item"><b>SonuÃ§ geÃ§erliliÄŸi:</b> 5 hafta</li>
                        </ul>
                    </div>

                    <div class="sub-section">
                        <h4 class="sub-section__title">IAP EndikasyonlarÄ±</h4>
                        <ul class="feature-list">
                            <li class="feature-item"><b>Pozitif GBS taramasÄ±</b> (en sÄ±k endikasyon)</li>
                            <li class="feature-item"><b>GBS bakteriÃ¼risi</b> mevcut gebelikte (herhangi bir dÃ¶nemde)</li>
                            <li class="feature-item"><b>Ã–nceki bebekte invaziv GBS hastalÄ±ÄŸÄ±</b></li>
                            <li class="feature-item"><b>Bilinmeyen GBS durumu</b> + risk faktÃ¶rÃ¼:
                                <ul>
                                    <li>- <37 hafta doÄŸum</li>
                                    <li>- Membran rÃ¼ptÃ¼rÃ¼nden â‰¥18 saat geÃ§mesi</li>
                                    <li>- Ä°ntrapartum ateÅŸ â‰¥38Â°C</li>
                                </ul>
                            </li>
                        </ul>
                    </div>

                    <div class="highlight-box">
                        <p class="highlight-box__title">IAP Rejimi</p>
                        <p class="highlight-box__content">
                            <strong>Ä°lk seÃ§enek:</strong> Penisilin G 5 milyon Ãœ IV yÃ¼kleme, ardÄ±ndan 2.5-3 milyon Ãœ her 4 saatte doÄŸuma kadar<br>
                            <strong>Alternatif:</strong> Ampisilin 2 g IV yÃ¼kleme, ardÄ±ndan 1 g her 4 saatte<br>
                            <strong>Penisilin alerjisi:</strong> Sefazolin, klindamisin veya vankomisin<br>
                            <strong>Optimal sÃ¼re:</strong> DoÄŸumdan en az 4 saat Ã¶nce baÅŸlanmalÄ±
                        </p>
                    </div>

                    <div class="alert-box alert-box--success">
                        <span class="alert-box__icon">âœ…</span>
                        <p class="alert-box__text"><strong>BaÅŸarÄ±:</strong> IAP uygulamasÄ± ile erken baÅŸlangÄ±Ã§lÄ± GBS hastalÄ±ÄŸÄ± insidansÄ± %80 azalmÄ±ÅŸtÄ±r (1990'lardan bu yana). Ancak geÃ§ baÅŸlangÄ±Ã§lÄ± hastalÄ±k Ã¼zerine etkisi yoktur.</p>
                    </div>
                `
            },
            {
                title: "Epidemiyoloji",
                icon: "fas fa-globe",
                content: `
                    <p>GBS dÃ¼nya genelinde Ã¶nemli bir perinatal patojendir:</p>

                    <ul class="feature-list">
                        <li class="feature-item"><b>Kolonizasyon oranÄ±:</b> Gebe kadÄ±nlarÄ±n %15-30'u</li>
                        <li class="feature-item"><b>Vertikal geÃ§iÅŸ:</b> Kolonize annelerin bebeklerinin %50'si kolonize olur</li>
                        <li class="feature-item"><b>HastalÄ±k geliÅŸimi:</b> Kolonize bebeklerin %1-2'sinde</li>
                        <li class="feature-item"><b>Erken baÅŸlangÄ±Ã§lÄ± insidans:</b> 0.2-0.5/1000 canlÄ± doÄŸum (IAP sonrasÄ±)</li>
                        <li class="feature-item"><b>GeÃ§ baÅŸlangÄ±Ã§lÄ± insidans:</b> 0.3-0.4/1000 canlÄ± doÄŸum</li>
                    </ul>

                    <div class="highlight-box">
                        <p class="highlight-box__title">Risk FaktÃ¶rleri</p>
                        <p class="highlight-box__content">
                            <strong>YenidoÄŸan iÃ§in:</strong> PrematÃ¼rite, dÃ¼ÅŸÃ¼k doÄŸum aÄŸÄ±rlÄ±ÄŸÄ±, uzamÄ±ÅŸ membran rÃ¼ptÃ¼rÃ¼, maternal ateÅŸ, yÃ¼ksek maternal kolonizasyon<br>
                            <strong>EriÅŸkin iÃ§in:</strong> Diyabet, obezite, malignite, immÃ¼nsÃ¼presyon, ileri yaÅŸ
                        </p>
                    </div>

                    <div class="sub-section">
                        <h4 class="sub-section__title">AÅŸÄ± GeliÅŸtirme Ã‡alÄ±ÅŸmalarÄ±</h4>
                        <ul class="feature-list">
                            <li class="feature-item">KapsÃ¼ler polisakkarit konjuge aÅŸÄ±lar deneme aÅŸamasÄ±nda</li>
                            <li class="feature-item">Hedef: Gebelikte maternal aÅŸÄ±lama â†’ Transplasental antikor transferi</li>
                            <li class="feature-item">Hem erken hem geÃ§ baÅŸlangÄ±Ã§lÄ± hastalÄ±ÄŸÄ± Ã¶nleme potansiyeli</li>
                        </ul>
                    </div>

                    <div class="mnemonic-box">
                        <p class="mnemonic-box__label">GBS Ã–zet</p>
                        <p class="mnemonic-box__text">CAMPing with Baby</p>
                        <p class="mnemonic-box__hint">CAMP (+), Baby (yenidoÄŸan en sÄ±k etken)</p>
                    </div>
                `
            },
            {
                title: "SÄ±nav Ä°Ã§in Kritik Noktalar",
                icon: "fas fa-graduation-cap",
                content: `
                    <div class="highlight-box">
                        <p class="highlight-box__title">TUS/Yeterlilik Klasikleri</p>
                        <p class="highlight-box__content">
                            1. <strong>YenidoÄŸan sepsis ve menenjitinin EN SIK etkeni</strong><br>
                            2. <strong>CAMP testi POZÄ°TÄ°F</strong> (ok ucu hemoliz)<br>
                            3. <strong>HipÃ¼rat hidrolizi POZÄ°TÄ°F</strong><br>
                            4. <strong>Basitrasin DÄ°RENÃ‡LÄ°</strong> (GAS duyarlÄ±)<br>
                            5. <strong>Serotip III</strong> = Menenjit<br>
                            6. Tarama: <strong>36-37. hafta</strong>, vajino-rektal sÃ¼rÃ¼ntÃ¼<br>
                            7. IAP ile <strong>erken baÅŸlangÄ±Ã§lÄ±</strong> hastalÄ±k Ã¶nlenir, geÃ§ baÅŸlangÄ±Ã§lÄ± Ã¶nlenmez
                        </p>
                    </div>

                    <table class="article-table">
                        <tr>
                            <th>Test</th>
                            <th>GBS (S. agalactiae)</th>
                            <th>GAS (S. pyogenes)</th>
                        </tr>
                        <tr>
                            <td>Hemoliz</td>
                            <td>Î²</td>
                            <td>Î²</td>
                        </tr>
                        <tr>
                            <td>CAMP</td>
                            <td><b>POZÄ°TÄ°F</b></td>
                            <td>Negatif</td>
                        </tr>
                        <tr>
                            <td>HipÃ¼rat</td>
                            <td><b>POZÄ°TÄ°F</b></td>
                            <td>Negatif</td>
                        </tr>
                        <tr>
                            <td>Basitrasin</td>
                            <td><b>DÄ°RENÃ‡LÄ°</b></td>
                            <td>DuyarlÄ±</td>
                        </tr>
                        <tr>
                            <td>PYR</td>
                            <td>Negatif</td>
                            <td><b>POZÄ°TÄ°F</b></td>
                        </tr>
                        <tr>
                            <td>Lancefield</td>
                            <td>Grup B</td>
                            <td>Grup A</td>
                        </tr>
                    </table>

                    <ul class="feature-list">
                        <li class="feature-item"><b>Soru tipi:</b> "YenidoÄŸanda sepsis + menenjit etkeni?" â†’ S. agalactiae (GBS)</li>
                        <li class="feature-item"><b>Soru tipi:</b> "CAMP testi pozitif streptokok?" â†’ S. agalactiae</li>
                        <li class="feature-item"><b>Soru tipi:</b> "Gebelikte 36. hafta taramasÄ± hangi bakteri iÃ§in?" â†’ GBS</li>
                        <li class="feature-item"><b>Soru tipi:</b> "Basitrasin direnÃ§li, Î²-hemolitik streptokok?" â†’ GBS</li>
                        <li class="feature-item"><b>Soru tipi:</b> "Ä°ntrapartum profilaksi hangi etken iÃ§in?" â†’ GBS</li>
                        <li class="feature-item"><b>Soru tipi:</b> "HipÃ¼rat hidrolizi pozitif streptokok?" â†’ S. agalactiae</li>
                    </ul>
                `
            }
        ]
    }
];

// Global export for dock.js
window.topicsData = topicsData;
